[Astute Analytica Press Release] We have conducted a survey to understand the state of the dermatological drug market in 2022.
It is mostly observed that many cancer patients are major consumers of the dermatological drug market market.
Survey period: September 1st to November 24th, 2022
Research agency :
Survey contractor: Astute Analytica Co., Ltd.
Survey target: The survey was conducted with 890 leaders from organizations of all sizes around the world.
Number of valid responses: (890 people)
Survey method: Telephone survey of 300 people, Internet survey of 590 people Survey Respondents: The survey was conducted across companies based on revenue. [Image 1
Survey results :
Q: What types of drugs are popular in dermatology?
Based on drug type, the dermatological drug market is segmented into branded prescription drugs, generic prescription drugs, and
over-the-counter (OTC) drugs. Among these, branded prescription drugs are expected to hold the largest market share and dominate the market in 2022.
Q: Which formulation has the highest share in the dermatological market? The ointment segment is projected to hold the highest market share in 2022 and maintain its dominance. and others are important factors driving the demand for ointments globally.
Q: What is the common route of administration?
In 2022, the topical medicine segment accounted for the major share of 53.3%. [Image 4
Q: Which therapeutic application has the highest share in the dermatological drug market?
In 2022, the psoriasis segment is expected to hold the largest market share at 39%. There are several new options for diagnosing and treating psoriasis in emerging countries.
Q: How is the dermatology market segmented by distribution channel? Based on distribution channel, the market is classified into retail channel, non-retail channel, and online channel. Among these, the retail channel holds the highest segment share in 2022.
Q: What are the key factors driving the dermatology market?
People are in increasing demand for skin and hair related formulas: Increased demand for dermatological drugs is driven by increasing demand for skin and hair related formulations such as anti-acne agents, emollients, hair regrowth agents, anti-fungal agents and whitening agents.
Consumers, especially millennials and Gen Z, are more conscious and conscious about their skin and hair. Also, increased disposable income allows consumers to spend more money on skincare products for a better skincare regime.
Rising skin-related diseases in people: Skin diseases have been called the most common cause of human illness, affecting almost one-third of the world’s population. Some skin conditions are genetic, while others are caused by lifestyle factors. Treatment of skin-related disorders can be done using medications, creams or ointments, or lifestyle changes.
Climate change has brought about serious changes to the global environment. Air pollution from halocarbon refrigerants, solvents, propellants, and blowing agents (chlorofluorocarbons (CFCs), HCFCs, halons) contributes to the depletion of the ozone layer. This thinning of the ozone layer makes it easier for harmful ultraviolet rays to penetrate, and skin diseases such as skin cancer and eye diseases are increasing.
Read more: https://bit.ly/3HKSZ2B
Astute Analytica is a global analytics and advisory firm that has built a strong reputation in a short period of time for the tangible results it has delivered to its clients. We pride ourselves on producing unparalleled depth and accuracy of estimates and forecasts for our highly demanding clients in a variety of industries. We have a list of satisfied and repeat customers from various sectors such as Technology, Healthcare, Chemicals, Semiconductors and FMCG. These customers come to us from all over the world. This is because it analyzes the complex business environment, existing and emerging opportunities by segment, technology formations, growth projections, as well as available strategic options. In short, it’s a complete package. It is a highly qualified and prioritized team of business analysts, economists, consultants and technology experts.
Cost-effective, value-added best when it comes to working with us This press release
Details about this release: